(InSilico Medicine) Insilico enters into a research collaboration with Boehringer Ingelheim to apply novel generative artificial intelligence system for discovery of potential therapeutic targets.

Original source: https://www.eurekalert.org/pub_releases/2020-04/im-icw041420.php